C.P. Massard
Impact in
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
-
- Prostate Cancer Treatment and Research
- Sarcoma Diagnosis and Treatment
Papers in
-
- Cancer Genomics and Diagnostics 7
-
- Prostate Cancer Treatment and Research 4
- Sarcoma Diagnosis and Treatment 2
- Renal cell carcinoma treatment 2
- Co-authors
- Jean‐Charles Soria (4 shared papers)B. Bui (1 shared paper)Alain Moussy (1 shared paper)Jean‐Yves Blay (2 shared papers)P. Armand (1 shared paper)Olivier Hermine (1 shared paper)Colin D. Mansfield (1 shared paper)Nicolas Magné (1 shared paper)
- Journals
- Annals of Oncology (12 papers)European Journal of Cancer (9 papers)ESMO Open (3 papers)Lung Cancer (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- FranceUnited KingdomSpain
In The Last Decade
C.P. Massard
25 papers receiving 255 citations
Peers
Comparison fields: 5 of 53
- Gastroenterology 33
- Pulmonary and Respiratory Medicine 85
- Hematology 30
- Cancer Research 36
- Oncology 48
Countries citing papers authored by C.P. Massard
This map shows the geographic impact of C.P. Massard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.P. Massard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.P. Massard more than expected).
Fields of papers citing papers by C.P. Massard
This network shows the impact of papers produced by C.P. Massard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.P. Massard. The network helps show where C.P. Massard may publish in the future.
Co-authors
The 25 scholars most cited alongside C.P. Massard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 69 | |
| 2 | 2013 | 25 | |
| 3 | 2016 | 25 | |
| 4 | 2016 | 24 | |
| 5 | 2009 | 19 | |
| 6 | 2015 | 16 | |
| 7 | 2010 | 14 | |
| 8 | 2021 | 12 | |
| 9 | 2008 | 11 | |
| 10 | 2015 | 9 | |
| 11 | 2015 | 9 | |
| 12 | 2009 | 5 | |
| 13 | 2015 | 4 | |
| 14 | 2011 | 3 | |
| 15 | 2015 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2015 | 2 | |
| 18 | 2015 | 2 | |
| 19 | 2019 | 2 | |
| 20 | 2019 | 2 |
About C.P. Massard
C.P. Massard is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine, having authored 28 papers that have together received 264 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Treatment and Research (4 papers), RNA modifications and cancer (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Microtubule and mitosis dynamics (2 papers), Protein Degradation and Inhibitors (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Gastroenterology (33 citations), Pulmonary and Respiratory Medicine (85 citations), Hematology (30 citations), Cancer Research (36 citations) and Oncology (48 citations). C.P. Massard has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include Jean‐Charles Soria, B. Bui, Alain Moussy, Jean‐Yves Blay, P. Armand, Olivier Hermine, Colin D. Mansfield, Nicolas Magné, Yohann Loriot and Antonin Lévy. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, ESMO Open, Lung Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.